Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
124 participants
OBSERVATIONAL
2007-10-31
2009-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Anti-Psychotic in GPs Setting
NCT00543088
Observational Study to Evaluate Efficacy and Remission Status for Schizophrenia Patients Under Atypical Treatment
NCT00809731
Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder
NCT01769014
Subjective Well Being of Schizophrenic Patients in Greece
NCT00857064
An Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia
NCT01634542
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Prof Vermylen
Role: PRINCIPAL_INVESTIGATOR
UZ Leuven
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Aalst, , Belgium
Research Site
Asse, , Belgium
Research Site
Bertrix, , Belgium
Research Site
Bierbeek, , Belgium
Research Site
Boechout, , Belgium
Research Site
Bon-Secours, , Belgium
Research Site
Brussels, , Belgium
Research Site
Dendermonde, , Belgium
Research Site
Diest, , Belgium
Research Site
Duffel, , Belgium
Research Site
Eeklo, , Belgium
Research Site
Embourg, , Belgium
Research Site
Floreffe, , Belgium
Research Site
Ghent, , Belgium
Research Site
Halle, , Belgium
Research Site
Henri-Chapelle, , Belgium
Research Site
Herstal, , Belgium
Research Site
Ixelles-Elsene, , Belgium
Research Site
Jambes, , Belgium
Research Site
Kortenberg, , Belgium
Research Site
Kortrijk, , Belgium
Research Site
La Louvière, , Belgium
Research Site
Leut, , Belgium
Research Site
Leuven, , Belgium
Research Site
Libramont, , Belgium
Research Site
Lierneux, , Belgium
Research Site
Liège, , Belgium
Research Site
Melle, , Belgium
Research Site
Menen, , Belgium
Research Site
Mol, , Belgium
Research Site
Mons, , Belgium
Research Site
Ostend, , Belgium
Research Site
Ottignies, , Belgium
Research Site
Roeselare, , Belgium
Research Site
Schaarbeek, , Belgium
Research Site
Sint-Kruis (Brugge), , Belgium
Research Site
Sint-Michiels, , Belgium
Research Site
Sint-Niklaas, , Belgium
Research Site
Sint-Truiden, , Belgium
Research Site
Sleidinge, , Belgium
Research Site
Tielt, , Belgium
Research Site
Tienen, , Belgium
Research Site
Veurne, , Belgium
Research Site
Waregem, , Belgium
Research Site
Woluwe-Saint-Lambert, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-NBE-SER-2006/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.